fbpx

X

Elligo Health Research, Linden Capital and Ontario Teachers’ Pension Plan Partner to Launch Clinical Research Platform

Elligo Health Research, Linden Capital and Ontario Teachers’ Pension Plan Partner to Launch Clinical Research Platform

Linden Capital Partners and Ontario Teachers’ Pension Plan are investing in an initiative with Elligo Health Research to create an efficient, integrated clinical research ecosystem.

Chicago-based Linden Capital Partners and Canada’s Ontario Teachers’ Pension Plan are partnering with Elligo Health Research to launch a platform focused on advancing clinical research.

According to a press release, Linden and Ontario Teachers will invest in “exceptional companies deploying cutting-edge technology to foster seamless connections and collaborations among patients, research sites, pharmaceutical companies and the broader clinical research community.”

The strategic initiative will be headed by Elligo Chairperson John Potthoff, PhD, and will involve investment in companies and technology pursuing connections and collaborations among patients, research sites, pharmaceutical companies and the broader clinical research community.

This collaboration aims to leverage Elligo’s expertise in healthcare research, utilizing their innovative approaches to clinical trials.

Linden Capital Partners, known for its focus on healthcare investments, and Ontario Teachers’ Pension Plan, with its significant investment capabilities valued at $186 billion, bring substantial financial and strategic support to the table.

Valued at $8 billion, Linden was founded in 2004 and states it is the largest dedicated healthcare private equity firm in the US based on total capital raised after having invested in over 40 companies. The firm focuses on middle-market companies in medical products, specialty distribution, pharmaceutical and services segments of healthcare.


XTALKS WEBINAR: Psychedelic Therapy: Is the Future of Mental Healthcare Finally Here?

Live and On-Demand: Thursday, March 21, 2024, at 1pm EDT (10am PDT)

Register for this free webinar to join the Elligo Elite Learning Series roundtable for an open discussion on shaping the future of mental healthcare with psychedelic therapy research.


The partners said the vision of the initiative is for a unified and efficient clinical research ecosystem through the integration of strategic mergers and acquisitions along with technological advancements. The goal is to create streamlined, efficient and optimized processes through collaboration across all aspects of clinical research, from patient engagement to regulatory submissions.

“We believe our collaboration is a potential game-changer for clinical research. We see a significant gap in the industry and believe this strategic alliance will drive meaningful change and opportunity,” said Dr. Potthoff in the press release announcing the joint venture.

“By integrating leading companies and leveraging advanced technologies, we aim to create a cohesive and interconnected clinical research environment. Recognizing the unique needs of each therapeutic and scientific area, we aim to streamline processes, enhance efficiencies and foster collaborations that benefit all stakeholders, especially patients.”


Related: How Tendo’s Acquisition of MDsave Aims to Improve Healthcare Consumerism


On Linden’s side, the firm’s Operating Partner Margaret Keegan will lead the partnership. Keegan has held executive roles within clinical development at large pharmaceutical and contract research organization (CRO) companies, including PPD, IQVI and PRA Health Sciences. She was also the former chair of the Board for Clinical Data Interchange Standards Consortium (CDISC) and served as CEO of medtech service provider RQM+.

“I am excited to collaborate with Dr. Potthoff, Linden and Ontario Teachers to realize our shared vision,” said Keegan. “We recognize the inefficiencies and shortcomings of clinical research services that impact patients, research sites, sponsors and regulators, leading to delays in getting critical therapies to patients in need. Our commitment is to address these challenges head-on and catalyze positive change in our industry.”

The financial specifics of the partnership have not been revealed.

Established in 1990, Ontario Teachers’ Pension Plan is a global investor, investing in over 50 countries across a range of assets including public and private equities, fixed income, credit, commodities, natural resources, infrastructure, real estate and venture growth to deliver retirement income for 336,000 working members and pensioners, according to the group.